Brighter’s subsidiary Nectarine Health has obtained a regulatory clearance in the US linked to electronic communications (FCC) for two out of the three system units, the wristband and one of the plug-in units. The company is continuing its preparations for the announced US commercial launch, which is planned for the second half of 2021. Nectarine Health recently announced that the company initiated a test phase ahead of the launch. Read more about this here.
For further information, please contact:
Brighter Investor Relations
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company’s shares are listed on Nasdaq First North Growth Market/BRIG.